- JP-listed companies
- CanBas Co.,Ltd.
- Financials
- Total current liabilities
CanBas Co.,Ltd. (4575)
Market cap
¥14.8B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| Period End | Total current liabilities (Million JPY) | YoY (%) |
|---|---|---|
| Jun 30, 2025 | 107 | +16.19% |
| Jun 30, 2024 | 92 | -40.21% |
| Jun 30, 2023 | 154 | -10.90% |
| Jun 30, 2022 | 173 | +60.42% |
| Jun 30, 2021 | 108 | -61.05% |
| Jun 30, 2020 | 276 | +26.16% |
| Jun 30, 2019 | 219 | +40.12% |
| Jun 30, 2018 | 156 | +136.23% |
| Jun 30, 2017 | 66 | +73.56% |
| Jun 30, 2016 | 38 | +15.27% |
| Jun 30, 2015 | 33 | +26.44% |
| Jun 30, 2014 | 26 |